TELO insider filings

Telomir Pharmaceuticals, Inc. — 17 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-07-27. Screen TELO transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for TELO between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Telomir Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2026-07-274Del Giudice Matthew Paul — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-07-274MacPherson Edward Clouston — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-07-274Whalen Matthew Pratt — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-05-224Aminov Erez — CEO and Chairman, DirectorGrant/award (A): 1,960,170 (derivative) · Disposition to issuer (D): 1,960,170 (derivative) · Grant/award (A): 2,000,000 (derivative) · Disposition to issuer (D): 2,000,000 (derivative)EDGAR
2026-05-224Whalen Matthew Pratt — DirectorGrant/award (A): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative)EDGAR
2026-05-224MacPherson Edward Clouston — DirectorGrant/award (A): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative)EDGAR
2026-05-224Del Giudice Matthew Paul — DirectorGrant/award (A): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative)EDGAR
2026-04-244Aminov Erez — CEO and Chairman, DirectorOther (J): 7,319,710 @ $1.37EDGAR
2025-05-304Aminov Erez — CEO and Chairman, DirectorGrant/award (A): 2,000,000 (derivative) @ $0 · Grant/award (A): 400,000 (derivative) @ $0EDGAR
2024-11-254Bay Shore Trust — 10% ownerGift (G): 100,000 (derivative)EDGAR
2024-09-044Yanez Michelle — Chief Financial OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR
2024-08-294Jerman Michael Allen — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-08-294MacPherson Edward Clouston — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-08-294Aminov Erez — CEO & Chairman, DirectorGrant/award (A): 1,960,170 (derivative) @ $0EDGAR
2024-08-294Del Giudice Matthew Paul — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-08-294Whalen Matthew Pratt — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-02-154Bay Shore Trust — 10% owner
McNulty Brian Patrick — 10% owner
Purchase (P): 49,000 @ $7 · Purchase (P): 40,000 @ $7 · Purchase (P): 49,000 @ $7EDGAR

Recent 8-K events — Telomir Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-188-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-068-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-178-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-168-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-148-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-108-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-158-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-088-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-208-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-308-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TELO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs